Skip to main content
. 2021 May-Jun;37(3):668–674. doi: 10.12669/pjms.37.3.3687

Table-II.

Comparison of demographics and laboratory findings of patients received LMWH.

Patients Received LMWH (n=253) Patients not Received LMWH (n=998) p
Age (years) 51.2±16 50.48±16.2 0.53
Gender (M/F) 125 / 128 553 / 445 0.07
Platelet (103uL) 238.4±92.2 240.08±84.2 0.79
Lymphocyte (103uL) 1.81±0.93 1.84±1.2 0.67
D-Dimer (ug/mL) 1.51±2.95 1.37±3.69 0.67
Fibrinogen (mg/dL) 605±245.9 570.5±190.6 0.22
INR 1.16±0.4 1.14±0.5 0.67
aPTT (sec) 29.78±4.7 28.74±4.6 0.04
≥ 5 DIC score (n) 11 (5.2%) 18 (3.2%) 0.36
≥ 4 SIC score (n) 7 (3%) 19 (2.1) 0.38
Clinical progress
 Discharge to home (n) 222 930 0.008
 Transfer to ICU (n) 21 43
 Mortality 10 25 0.19

aPTT = activated prothrombin time, DIC = Disseminated intravascular coagulation, F = Female, LMWH = Low molecular weight heparine, M = Male, ICU = Intensive care unit, INR = International normalized ratio, SIC = Sepsis-induced coagulopathy.